Literature DB >> 19021225

The painful face of poverty.

Jane Hankins1, Winfred Wang.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19021225      PMCID： PMC2744591          DOI： 10.1002/pbc.21856

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  9 in total

Review 1.  Comprehensive care in sickle cell disease: its impact on morbidity and mortality.

Authors:  E P Vichinsky
Journal:  Semin Hematol       Date:  1991-07       Impact factor: 3.851

2.  A recommitment to sickle cell disease research.

Authors:  Elizabeth G Nabel; Susan B Shurin
Journal:  Blood       Date:  2008-05-15       Impact factor: 22.113

3.  National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease.

Authors:  Otis W Brawley; Llewellyn J Cornelius; Linda R Edwards; Vanessa Northington Gamble; Bettye L Green; Charles Inturrisi; Andra H James; Danielle Laraque; Magda Mendez; Carolyn J Montoya; Brad H Pollock; Lawrence Robinson; Aaron P Scholnik; Melissa Schori
Journal:  Ann Intern Med       Date:  2008-05-05       Impact factor: 25.391

4.  Pain in children: comparison of assessment scales.

Authors:  D L Wong; C M Baker
Journal:  Pediatr Nurs       Date:  1988 Jan-Feb

5.  Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea.

Authors:  Sophie Lanzkron; Carlton Haywood; Jodi B Segal; George J Dover
Journal:  Am J Hematol       Date:  2006-12       Impact factor: 10.047

6.  Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Authors:  S Charache; M L Terrin; R D Moore; G J Dover; F B Barton; S V Eckert; R P McMahon; D R Bonds
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

7.  A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center: opportunities to improve healthcare quality.

Authors:  Jean L Raphael; Priya B Shetty; Hao Liu; Donald H Mahoney; Brigitta U Mueller
Journal:  Pediatr Blood Cancer       Date:  2008-11       Impact factor: 3.167

8.  The costs of children with sickle cell anemia: preparing for managed care.

Authors:  J H Bilenker; W E Weller; T J Shaffer; G J Dover; G F Anderson
Journal:  J Pediatr Hematol Oncol       Date:  1998 Nov-Dec       Impact factor: 1.289

9.  The use of transcranial ultrasonography to predict stroke in sickle cell disease.

Authors:  R Adams; V McKie; F Nichols; E Carl; D L Zhang; K McKie; R Figueroa; M Litaker; W Thompson; D Hess
Journal:  N Engl J Med       Date:  1992-02-27       Impact factor: 91.245
  9 in total
  6 in total

1.  Mistrust of Pediatric Sickle Cell Disease Clinical Trials Research.

Authors:  Evelyn M Stevens; Chavis A Patterson; Yimei B Li; Kim Smith-Whitley; Lamia P Barakat
Journal:  Am J Prev Med       Date:  2016-07       Impact factor: 5.043

Review 2.  The Case for Pharmacogenetics-Guided Prescribing of Codeine in Children.

Authors:  Roseann S Gammal; Kelly E Caudle; Charles T Quinn; Winfred C Wang; Andrea Gaedigk; Cynthia A Prows; Cyrine E Haidar; Annette K Taylor; Teri E Klein; Katrin Sangkuhl; Jane S Hankins; Kristine R Crews
Journal:  Clin Pharmacol Ther       Date:  2018-11-22       Impact factor: 6.875

3.  Social-environmental factors and cognitive and behavioral functioning in pediatric sickle cell disease.

Authors:  Sarah E Bills; Jeffrey Schatz; Steven J Hardy; Laura Reinman
Journal:  Child Neuropsychol       Date:  2019-02-21       Impact factor: 2.500

4.  The Meaning of Informed Consent: Genome Editing Clinical Trials for Sickle Cell Disease.

Authors:  Stacy Desine; Brittany M Hollister; Khadijah E Abdallah; Anitra Persaud; Sara Chandros Hull; Vence L Bonham
Journal:  AJOB Empir Bioeth       Date:  2020-10-12

5.  Insurance status as a sociodemographic risk factor for functional outcomes and health-related quality of life among youth with sickle cell disease.

Authors:  M Renee Robinson; Lauren C Daniel; Emily A O'Hara; Margo M Szabo; Lamia P Barakat
Journal:  J Pediatr Hematol Oncol       Date:  2014-01       Impact factor: 1.289

6.  Bright IDEAS problem-solving skills training for caregivers of children with sickle cell disease: A two-site pilot feasibility trial.

Authors:  Melissa Young; Megan Voll; Robert B Noll; Diane L Fairclough; Cate Flanagan-Priore
Journal:  Pediatr Blood Cancer       Date:  2020-12-23       Impact factor: 3.167
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.